- XV Eurasian Hematology-Oncology Congress - EHOC 2024
- XIV Eurasian Hematology-Oncology Congress - EHOC 2023
- 8th Eurasian Hematology Oncology Summit
- XIth Eurasian Hematology-Oncology Congress - EHOC 2020
- 7th Eurasian Hematology Oncology Summit
- Xth Eurasian Hematology-Oncology Congress
- Events

Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
0:00
Stream Type LIVE
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
How I Treat Newly Diagnosed MM in 2020: Is VTD Superior to VCD? Is D-VTd Beneficial for PFS/OS in Transplant-Eligible Disease? Should We Use Thalidomide Maintenance After ASCT?
By
7th Eurasian Hematology Oncology Summit
FEATURING
Angelo Maiolino
By
7th Eurasian Hematology Oncology Summit
FEATURING
Angelo Maiolino
147 views
December 9, 2020
Comments 0
Login to view comments.
Click here to Login
Myeloma